Investview - INVUP STOCK NEWS

Investview (OTCQB: INVU) reported Q3 2024 financial results showing decreased revenue but improved cash position. Gross revenue declined 39.1% to $12.6M, while net revenue decreased 38.7% to $11.7M compared to Q3 2023. The company reported a net loss of $0.7M, including a $977K non-cash impairment charge on mining equipment. Despite revenue challenges, cash position strengthened to $24.5M, up 16.9% from December 2023. The company announced plans to launch Opencash brokerage business in H1 2025 and expand into health and wellness through myLife Wellness Company and Renu Laboratories acquisition.

Investview (OTCQB: INVU) has acquired Renu Laboratories, a manufacturer of health, beauty and wellness products. The acquisition will launch a new health and wellness business unit called myLife Wellness, operating through a B2C direct-to-consumer model. Renu Labs brings proprietary products including advanced peptide serums and operates as an FDA-registered, cGMP-compliant facility. The merger is expected to be revenue accretive by Q4 2024-Q1 2025, leveraging Investview's existing network of over 15,000 global customers and members. The company aims to expand product offerings and enhance customer retention through its iGenius global network.

Investview, Inc. (OTCQB: INVU) reported its Q2 2024 financial results, showing mixed performance. Gross revenue decreased 26.0% to $13.8 million, while net revenue fell 24.1% to $13.1 million compared to Q2 2023. However, for the six months ended June 30, 2024, net income from operations increased 45.2% to $2.3 million. The company's cash position improved, with cash and cash equivalents up 13.1% to $23.7 million from December 31, 2023.

iGenius and SAFETek, Investview's operating subsidiaries, faced challenges due to global economic headwinds and industry-specific factors like Bitcoin halving. Despite these obstacles, the company remains focused on its strategic transformation plan, exploring new business channels and potential acquisitions to drive long-term growth.

Investview (OTCQB: INVU) announced its Q1 2024 financial results, reporting significant growth across key metrics compared to Q1 2023. Gross revenue increased by 11.4% to $16.5 million, while net revenue rose 15.5% to $15.7 million. Net income from operations saw a substantial jump of 376.7% to $1.9 million. The company’s cash position improved, with cash and equivalents at $24.4 million, up 16.8% from December 2023. iGenius, a major subsidiary, achieved a 13.6% increase in net revenue to $13.0 million, driven by a 16.4% rise in subscription revenue. SAFETek's revenue also grew by 26.2% due to the rising value of Bitcoin. Despite a 25.7% increase in total liabilities to $18.7 million and a decrease in stockholders’ equity by 8.9% to $17.1 million, the repurchase of 472 million shares helped reduce outstanding shares by 20.2%. Investview's strategic moves, including the acquisition of Opencash Securities, aim at expanding its retail brokerage and financial markets presence, setting the stage for future growth.

Investview reports a 9.4% increase in gross revenue to $72.9 million and a 153.5% rise in net income from operations to $4.6 million for the twelve months ended December 31, 2023. The company also reduced outstanding debt by 65.9% and repurchased over 775 million common shares, resulting in a decrease of 29.4% in issued and outstanding shares. Investview acquired Opencash Securities, to expand into the retail brokerage and financial markets industry.

Investview, Inc. (INVU) has acquired Opencash Securities , an early-stage registered broker-dealer, to expand into the retail brokerage and financial markets industry. This strategic move aims to offer a self-directed retail brokerage platform to investors, integrating Opencash's online platform with Investview's algorithmic trading platform. The acquisition is expected to drive shareholder value by diversifying product offerings and tapping into the growing trend of self-directed investing in the US.

Investview, Inc. announced the repurchase and cancellation of 472,374,710 of its outstanding common shares, reducing its outstanding capitalization by 20.24%. The repurchased shares were bought at a price per share of $.007559985, representing a discount of approximately 57.6% to the average market price. The purchase price is payable over a two-year period in eight equal consecutive quarterly payments. The repurchase is part of the company's strategic initiatives to add shareholder value and reflects a bullish outlook for the company's long-term intrinsic value.

INVU - Investview, Inc. Reports Strong Financial and Operational Results for Q3 2023

Investview, Inc. announces its financial results for the three and six month periods ended June 30, 2023. Gross revenue increased 16.9% to $18.6 million for the three months ended June 30, 2023. Net revenue increased 16.9% to $17.3 million. Net cash provided by operating activities increased 945.3% to $4.4 million. Net income from operations decreased 24.4% to $1.2 million. For the six months ended June 30, 2023, gross revenue decreased 4.6% to $33.4 million. Net revenue decreased 5.2% to $30.8 million. Net cash provided by operating activities decreased 11.1% to $4.0 million. Net income from operations decreased 72.8% to $1.6 million. Cash and cash equivalents at June 30, 2023, was $21.4 million, up 4.7% from December 31, 2022. Total assets increased by 3.5% to $36.8 million. Outstanding debt decreased by $1.3 million to $9.2 million. Total stockholders’ equity increased by 3.5% to $36.8 million.